Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study
Researchers identified which blood sugar resistance measure best predicts heart risk in fatty liver patients, guiding doctors toward the most useful risk assessment.
A multicenter cohort study systematically compared multiple insulin resistance-related indices for predicting major adverse cardiovascular events in patients with NAFLD/MASLD, a rapidly growing cardiometabolic patient population. The comparative analysis identifies which IR index offers the most accurate CV risk stratification in NAFLD/MASLD, providing clinically actionable guidance for risk-based preventive strategies.
What the study was
- Study design
- Multicenter prospective cohort study comparing insulin resistance indices for CV event prediction in NAFLD/MASLD
- Population
- NAFLD/MASLD patients from multiple centers
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Cardiovasc Diabetol
Why it surfaced
Multicenter cohort study comparing IR indices for CV risk in NAFLD/MASLD; open-access Cardiovasc Diabetol; clinical utility for cardiometabolic risk stratification in large underserved population.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.